(Q53928769)

22 May 2018

title

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. (English)

1 reference

22 May 2018

main subject

cystic fibrosis

0 references

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

Durieu I

1

1 reference

22 May 2018

Pellet O

2

1 reference

22 May 2018

Simonot L

3

1 reference

22 May 2018

Durupt S

4

1 reference

22 May 2018

Bellon G

5

1 reference

22 May 2018

Durand DV

6

1 reference

22 May 2018

Minh VA

7

1 reference

22 May 2018

publication date

1 June 1999

1 reference

22 May 2018

published in

Journal of Hepatology

1 reference

22 May 2018

volume

30

1 reference

22 May 2018

issue

6

1 reference

22 May 2018

page(s)

1052-1056

1 reference

22 May 2018

Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Cystic fibrosis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Sclerosing cholangitis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Liver disease and bile duct abnormalities in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Biliary complications of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

The role of hepatobiliary scintigraphy in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Primary sclerosing cholangitis: a modified classification of cholangiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Intrahepatic cholangiographic appearance simulating primary sclerosing cholangitis in several hepatobiliary diseases: a postmortem cholangiographic and histopathological study in 154 livers at autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980259-1

7 January 2021

10.1016/S0168-8278(99)80259-1

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

10406183

1 reference

22 May 2018